Poster Abstract Session:
114. Antibiotic Stewardship: Theory and Practice
Friday, October 19, 2012: 12:30 PM-2:00 PM
Room: SDCC Poster Hall F-H

Topical Category: A. Antimicrobial Agents and P. Pediatric and Perinatal Infections

Tracks: Adult ID, Pediatric ID, Epidemiology and Infection Control

Presentations:

700
Impact of an Antimicrobial Stewardship Program at the University of Minnesota Medical Center,The First 5 Years, 2007-2011
Susan Kline, MD, MPH ; Kimberly Boeser, Pharm D ; Christine Hendrickson, RN, BSHA ; Anita Guelcher, RN, BSN ; Amanda Guspiel, MPH ; Teresa Rakoczy, RN, BSN ; Pamela Phelps, Pharm D

702
A Review Of Antimicrobial Use In The Medical Intensive Care Unit – A Need For Improvement?
Ramzy Rimawi, MD ; Muhammad Salman Ashraf, MD ; Mark Mazer, MD ; Badih Kabchi, MD ; Michael Gooch, RPh ; Paul Cook, MD
Posters
  • IDSA Poster.pdf (447.2 kB)

  • 703
    Experience with Mandatory Infectious Disease (ID) Consult for Outpatient Parenteral Antimicrobial Therapy (OPAT)
    Edemekong Bassey, MD ; Maninder Mahal, MD ; Rachel M Chambers, PharmD ; Susan L Davis, PharmD ; Indira Brar, MD
    Posters
  • OPAT FINAL IDSA.pdf (242.9 kB)

  • 705
    Antibiotic Stewardship in Long-Term Acute Care Facilities - The 7-Step Pyramid Approach
    Caitlin Biedron, M.S. ; Amar Krishna, MD ; Uzma Bashir, M.D. ; Olufemi Jegede, MPH ; Gary McGlaun, PharmD ; Hassan Chami, PharmD ; Andrew Escamilla, R.N., M.S. ; Lona Mody, MD, MSc ; Peter Lichtenberg, PhD ; Richard Severson, PhD ; Keith Kaye, MD, MPH, FIDSA, FSHEA ; Teena Chopra, MD, MPH

    706
    Housestaff Attitudes and Knowledge About Antibiotic Resistance: A Multicenter Survey
    Daniel Z. Uslan, MD, MS ; Andrew Lai, MD ; Jenny Banh, MD ; Christopher Graber, MD, MPH ; Jim Nomura, MD ; Lilian Abbo, MD ; Thomas M. Hooton, MD ; Ronda Sinkowitz-Cochran, MPH ; Arjun Srinivasan, MD, FSHEA

    707
    Antimicrobial Stewardship Initiatives in Cancer Patients: The MD Anderson Cancer Center Experience
    Frank Tverdek ; Cai Wu ; Coralia Mihu, MD ; Alma DeJesus ; Wendy Heck ; Kenneth Rolston, MD ; Roy Chemaly, MD, MPH, FACP, FIDSA

    709
    Implementation and Evaluation of an Active Intervention Antimicrobial Stewardship Program in a Medical-Surgical Intensive Care Unit (MS-ICU) in a Community Hospital Setting
    Glenn Myers, BScPharm ; Lindsay Creamer, BSc, BSc Pharm ; Joshua Murray, MSc ; Denise LeBlanc-Duchin, BSc, MA, PhD ; Sameh El-Bailey, MBCHB, DCP, FRCPath ; Joanne Salmon, MD, MPH
    Posters
  • J Salmon IDSA 2012 poster.pdf (307.1 kB)

  • 710
    Antibiotic Stewardship in an Inpatient Rehabilitaiton Hospital
    Steven Lewis, MD ; Nitika Agarwal, Pharm. D ; Helen Afolarin, Pharm. D ; Susan Isenberg, RN, CIC ; Sally Strong, RN, APN-CNS

    712
    The Presence of Antibiotic Stewardship/Restriction Programs: A National Survey
    Monika Pogorzelska, PhD, MPH ; Eli Perencevich, MD, MS, FIDSA, FSHEA ; Elaine Larson, PhD, RN, FIDSA, FSHEA ; E. Yoko Furuya, MD, MS ; Patricia Stone, PhD, MPH, RN, FAAN

    713
    Antimicrobial Stewardship Programs in Florida’s Acute Care Hospitals
    Lilian Abbo, MD ; Kaming Lo, MPH ; Ronda Sinkowitz-Cochran, MPH ; Anne Carol Burke, MA ; Richard S Hopkins, MD, MSPH ; Arjun Srinivasan, MD, FSHEA ; Thomas M. Hooton, MD

    715
    A Survey of Emergency Physicians' Attitudes Regarding Antibiotic Stewardship
    Gary R Kravitz, MD ; Cindy J Larson, PhD, MSPH ; Marsha N Studer, RN, MPH
    Posters
  • Poster ED Survey Final.pdf (329.1 kB)

  • 716
    Adherence to Published Antimicrobial Prophylaxis Guidelines for Wounded Service Members in the On-going Conflicts in Southwest Asia
    Bradley Lloyd, DO ; Amy Weintrob, MD ; Mary Hinkle, MD ; Nicholas Conger, MD ; Clinton K. Murray, MD ; Glenn Wortmann, MD ; Lakisha Gaskins, MHS ; Eugene Millar, PhD ; Faraz Shaikh, MS ; Kristen Vanderzant, BA ; Stacie Gregg, BA ; Gina Lloyd, BSN ; Julie Stevens, BSN ; David Tribble, MD, DrPH

    717
    The Impact of a Massachusetts State Sponsored Educational Program on Antimicrobial Stewardship for Acute Care Hospitals
    Adam Weston, M.D. ; Lauren Epstein, MD ; Alfred DeMaria Jr., MD ; Lisa E. Davidson, MD ; Shira Doron, MD

    719
    Philosophy vs. Practice: A Survey of Antimicrobial Stewardship in the United States 5 Years After the SHEA/IDSA Guidelines
    Patrick McDaneld, PharmD ; Daryl D. DePestel, PharmD, BCPS ; Kenneth C. Lamp, PharmD ; Thomas Chung, M.S. ; Peggy McKinnon, PharmD ; Monica Crompton, PharmD ; Elizabeth Hermsen, PharmD, MBA

    720
    Report of the U.S. Veterans Health Administration's (VHA) Antimicrobial Stewardship Inventory of Practices
    Allison Kelly, MD, MSOH ; Loretta Simbartl, MS ; Melinda Neuhauser, PharmD, MPH ; Gavin West, MD ; Gary Roselle, MD

    723
    Antibiotics and the risk of community-associated Clostridium difficile infection (CDI): a meta-analysis
    Kevin Brown, MSc ; Nagham Khanafer, PharmD ; Nick Daneman, MD, MSc ; David N. Fisman, MD

    724
    Antibiotic Use in Veterans Affairs Long-term-care Facilities: a Nationwide Analysis Using Barcode Medication Administration Data, 2007 - 2009
    Angela Huttner, MD ; Benedikt Huttner, MD ; Makoto Jones, MD, MS ; Michael Rubin, MD, PhD ; Christopher Nielson, MD, MPH ; Jeanmarie Mayer, MD ; Matthew Samore, MD, FSHEA

    725
    The impact of vancomycin resistance on the presentation, management, and outcomes of enterococcal bacteriuria
    Hani Khair, MD ; Paige VanTassell ; Jeffrey P. Henderson, MD PhD ; David K. Warren, MD, MPH ; Jonas Marschall, MD

    726
    Association between Vancomycin-Resistant Enterococcus Colonization and Clinically Significant Vancomycin-Resistant Enterococcus Infection in Critically Ill Patients
    Sheila Takieddine, Pharm.D. ; Eric Mueller, Pharm.D., FCCM ; Neil Ernst, Pharm.D. ; Maria Guido, Pharm.D., BCPS ; Michael Dowling ; Joseph Solomkin, MD
    Posters
  • Takieddine_VRE_PDF.pdf (535.5 kB)

  • 727
    Optimizing Antimicrobial Therapy in Intraabdominal Infections by a Multifaceted Implementation of an Internal Guideline
    Zagorka Popovski, PharmD, BSc ; Peter Delanghe, BSc ; Timothy Rice, MD ; Melani Sung, PharmD, BSc ; Miriam Tsao, BMSc ; Niv Sne, MD ; Cheryl Main, MD ; Dominik Mertz, MD, MSc

    728
    Institutional Outbreak of Linezolid-nonsusceptible Enterococccus faecium (LNEF) Emerges During Linezolid Cycling in a Surgical Intensive Care Unit (SICU)
    Heather Cox, PharmD ; Costi D. Sifri, MD ; Robert Sawyer, MD ; W. Michael Scheld, MD ; Amy Mathers, MD
    Posters
  • Abstract#37572.pdf (585.0 kB)

  • 731
    Effect of Clinical Pathways for Common Outpatient Infections on Antibiotic Prescribing:  A Cluster-Randomized Trial
    Timothy Jenkins, MD ; Amy Irwin, DNP, RN ; Letoynia Coombs, EdD ; Lauren DeAlleaume, MD ; Stephen Ross, MD ; Jeanne Rozwadowski, MD, MPH ; Brian Webster, MD ; Miriam Dickinson, PhD ; Allison Sabel, MD, PhD, MPH ; Thomas MacKenzie, MD, MSPH ; David West, PhD ; Connie Price, MD

    732
    Improving Appropriate Utilization of Procalcitonin in Hospitalized Patients with Suspected Infections
    Kelly Echevarria, PharmD ; Elena Laserna, MD/PhD ; Jose Cadena, MD ; Gregory Smith, DDS ; Amruta Parekh, MD, MPH ; Anisha Arora, MD ; Oriol Sibila, MD / PhD ; Antonio Anzueto, MD ; Marcos Restrepo, MD, MSc
    Posters
  • PCT_Kelly_IDWeek2012 final.pdf (647.5 kB)

  • 733
    Clinical Impact of a Positive Pneumococcal Urinary Antigen Test (UAT) on Antimicrobial Therapy (AT): A Stewardship Opportunity?
    Elizabeth Radigan, PharmD, BCPS ; Christy Capistran, PharmD, RN ; Iva Zivna, MD ; Jason Potts, PharmD ; Gail Scully, MD, MPH

    734
    Barriers to Rapid Antibiotic Delivery to Inpatients
    Chloe Bryson-Cahn, M.D. ; Mallory Witt, MD ; Megan Nguyen, PharmD ; Brad Spellberg, MD, FIDSA
    Posters
  • 734_ID.jpg (6.8 MB)

  • 735
    Antibiotic Stewardship Involving Anti-staphylococcal Beta-lactams at a Veterans Affairs Hospital
    Kelly Echevarria, PharmD ; Lindsey Childs, PharmD, MPH ; Elizabeth A. Oates, Pharm.D. ; Jose Cadena, MD

    737
    Impact of Hospital Pharmacists’ Clinical Interventions for Promoting Rational Utilization of Anti-infectives in a University Hospital in Lebanon
    Nabila Droubi, BS Pharmacy ; Dania Abdallah, Pharm D ; Lina Khayat, BS Pharmacy ; May Chmaitelly, BS Pharmacy ; Nada Iskandarani, Pharm D
    Posters
  • POSTER.pdf (850.4 kB)

  • 738
    Does Antimicrobial Stewardship of Outpatient Parenteral Antimicrobial Therapy (OPAT) at Hospital Discharge from an Academic Medical Center Reduce Complications?
    Monica Donnelley, PharmD, BCPS ; Cinda Christensen, PharmD, BCPS-ID ; Brett Heintz, PharmD, BCPS-ID, AAHIVE ; Jenana Halilovic, Pharm.D., BCPS ; Hien Nguyen, MD

    739
    Clinical and Financial Impact of the Replacement of Oxacillin with Cefazolin for MSSA Infections
    James S. Lewis II, PharmD, FIDSA ; Jason E. Bowling, MD ; Yolanda Laurel, RPh, MBA ; James H. Jorgensen, PhD
    Posters
  • IDSA Poster 2012 Lewis.pdf (1.1 MB)

  • 740
    An Antimicrobial Stewardship Effort Driven by Real Time Targeted Microbiology Culture Data
    John Dekker, MD, PhD ; JiYeon Kim, MD, MPH ; Christy Varughese, PharmD ; John Branda, MD ; Mary Jane Ferraro, PhD ; Eric Rosenberg, MD

    742
    Retrospective Evaluation of the Impact of an Antimicrobial Stewardship Program in a Teaching Hospital on Clinical and Economic Outcomes
    Desirae L. Lenzer, PharmD ; Tamara L. Trienski, PharmD ; Timothy R. Pasquale, PharmD ; Joseph P. Myers, MD, FACP, FIDSA ; Michael J. Tan, MD, FACP, FIDSA ; Dorcas Letting-Mangira, PharmD ; Thomas M. File Jr., MD, MSc, MACP, FIDSA, FCCP

    743
    Assessing the Adequacy of Documentation in Patients Receiving Antibiotic Therapy
    Lacey DeVreese, BSP ; Rosemary Zvonar, BScPhm, FCSHP ; Gary E. Garber, MD, FACP, FIDSA

    744
    Evaluation of the Impact of an Antimicrobial Stewardship Program in Patients with Acute Bacterial Skin and Soft-tissue Infections (ABSSI) at a Teaching Hospital
    Timothy R. Pasquale, PharmD ; Tamara L. Trienski, PharmD ; Deanna E. Olexia, RPh ; Joseph P. Myers, MD, FACP, FIDSA ; Michael J. Tan, MD, FACP, FIDSA ; Anthony Leung, DO, FACP, FASCP ; Jose E. Poblete, MD ; Thomas M. File Jr., MD, MSc, MACP, FIDSA, FCCP

    745
    Evaluation of an Antimicrobial Stewardship Program at a Teaching Hospital
    Tamara L. Trienski, PharmD ; Deanna E. Olexia, RPh ; Timothy R. Pasquale, PharmD ; Joseph P. Myers, MD, FACP, FIDSA ; Michael J. Tan, MD, FACP, FIDSA ; Jose E. Poblete, MD ; Anthony Leung, DO, FACP, FASCP ; Thomas M. File Jr., MD, MSc, MACP, FIDSA, FCCP

    746
    Impact of Carbapenem Use Stewardship Program to Reduce Carbapenem-resistant Pseudomonas aeruginosa
    Fumi Yamagami, MD ; Yoichiro Natori, MD ; Fumie Sakamoto, BSN, MPH, CIC ; Sachiko Ohde, Ed.M ; Keiichi Furukawa, MD

    747
    Experience with Ceftaroline (CFT) for Bone and Joint Infections
    Rene Gonzalez Jr., PharmD ; Rachel M Chambers, PharmD ; Susan L Davis, PharmD

    750
    Wide Variation in Antibiotic Utilization in Small Non-Metropolitan Hospitals
    Gary R Kravitz, MD ; Jessica S. Holt, PharmD, BCPS-ID ; Ross Fishman, PharmD

    751
    Impact of Gram Stain Findings on Ventilator Associated Pneumonia Therapy
    Julian Goodman, MD ; Jeremy Taylor, PharmD, BCPS ; Kurt Stevenson, MD, MPH

    752
    Management of Bone and Joint Infections (BJI) with Outpatient Parenteral Antimicrobial Therapy (OPAT) in a Veteran Population: Risk Factors for Failure of Therapy
    Leslie Bittner, Pharm.D. ; Sharanie Sims, Pharm.D., BCPS ; Amy Hirsch, Pharm.D., BCPS ; Usha Stiefel, M.D. ; Marion Skalweit, MD, PhD

    753
    Can Active Methicillin-Resistant Staphylococcus aureus Surveillance Increase Vancomycin Use? A Retrospective Analysis of Antibiotic Use and Microbiology Data from 129 Veterans Affairs Hospitals between 2005 and 2010
    Makoto Jones, MD, MS ; Benedikt Huttner, MD ; Angela Huttner, MD ; Christopher Nielson, MD, MPH ; Matthew Samore, MD, FSHEA ; Michael Rubin, MD, PhD

    754
    Initial Testing of a VA Enterprise Solution for Institutional Antibiograms
    Patricia Schirmer, MD ; Renee C. Mercier, Pharm.D. ; Russell Ryono, Pharm. D. ; Cynthia Lucero, MD ; Gina Oda, MS ; Mark Holodniy, MD

    755
    Hitting the Target:  Outcomes of a Pharmacy-Managed Vancomycin Dosing and Monitoring Strategy at a Tertiary-Care VA Medical Center
    Jennifer Luxenburg, PharmD ; Sharanie Sims, Pharm.D., BCPS ; Mandy Roesel, PharmD ; Christopher Lacey, PharmD ; Amy Hirsch, Pharm.D., BCPS ; Usha Stiefel, M.D.

    756
    Savings after Implementation of an Extended Infusion Zosyn Dosing Protocol in the ICU
    Jerusha Taylor, Pharm D ; Graeme Forrest, MBBS ; Joe Fazio, RPh, MHA ; Josh Weigel, PharmD

    757
    Evaluation of the microorganisms isolated from cancer patients with fever and chemotherapy-induced neutropenia presenting to the Emergency Department at the University of Florida
    Laura Lourdes, MD ; Jonathan DeGroat, MD ; Michael Falgiani, MD ; Kenneth Klinker, PharmD ; Wei Hou, PhD ; John Hiemenz, MD ; Priya Gopalan, MD/PhD
    Posters
  • IDSA_Poster_v9.pdf (437.6 kB)

  • 761
    Role of procalcitonin in guiding antibiotic therapy: A review of all randomized controlled trials
    Mitu Maskey, MD ; Tasaduq Fazili, MD ; Waleed Javaid, MD ; Timothy Endy, MD, MPH

    762
    Combination Antimicrobial Therapy versus Monotherapy for Pseudomonas Blood Stream Infections
    J. Alexander Viehman, MD ; Meganne Kanatani, Pharm.D. ; Romney M. Humphries, Ph.D. ; Brandy Bryant, MPH ; Zachary Rubin, MD ; Daniel Z. Uslan, MD, MS

    763
    Antibiotic Susceptibility Trends in California Hospitals: Results from the California Antibiogram Project, 2008 - 2010
    Kelsey Oyong, MPH ; Janet A. Hindler, MCLS, MT ; Jon Rosenberg, MD ; Kavita K. Trivedi, MD

    764
    Clindamycin use in the United States 2000-2009
    Michael Smith, MD, MSCE ; John Myers, PhD ; Savitri Appana, MS ; Charles Woods, MD, MS, FIDSA, FSHEA

    766
    The Inappropriate Diagnosis and Treatment of Ventilator-Associated Pneumonia is Common in Medical and Surgical Intensive Care Units
    V. Nussenblatt, MD, MHS ; Edina Avdic, PharmD, MBA ; Sean M. Berenholtz, MD, MHS, FCCM ; Taylor Carlson ; Elizabeth Daugherty ; Vidhya Gunaseelan, MS, MHA ; Eric Hadhazy ; Pamela Lipsett, MD ; Lisa L. Maragakis, MD, MPH ; Trish M. Perl, MD, MSc, FIDSA, FSHEA ; Kathleen Speck, MPH ; S Swoboda, RN, MS ; Wendy Ziai ; Sara Cosgrove, MD, MS, FIDSA, FSHEA
    Posters
  • posterIDweek-2.pdf (518.3 kB)

  • 767
    Inadequacy of Antibacterial Prescriptions in Obese and Morbidly Obese Adults
    Vincent Nault, B.Sc. ; Stephanie Sirard, M.Sc. ; Marie-France Langlois, M.D. ; Julie Perron, B.Pharm., M.Sc. ; Mathieu Beaudoin, M.Sc. ; Louis Valiquette, MD

    768
    Indications and Types of Antibiotic Use In Six Acute-Care Hospitals: Results from a Multicenter Cross-Sectional Study
    Daniel Z. Uslan, MD, MS ; Theodoros Kelesidis, MD ; Nikolay Braykov, BSE ; Daniel Morgan, MD, MS ; Birgir Johannsson, MD ; Marin Schweizer, PhD ; Scott A. Weisenberg, MD, MSc, DTM&H ; Heather Young, MD ; Joseph Cantey, MD ; Eli Perencevich, MD, MS, FIDSA, FSHEA ; Edward Septimus, MD, FIDSA, FSHEA ; Arjun Srinivasan, MD, FSHEA ; Ramanan Laxminarayan, PhD, MPH
    Posters
  • IDWeek-CDDEP Uslan.pdf (572.6 kB)

  • 769
    Prior Antibiotic Allergies and Adverse Reactions: Results from a Multicenter Cross-Sectional Study
    Scott A. Weisenberg, MD, MSc, DTM&H ; Nikolay Braykov, BSE ; Marin Schweizer, PhD ; Daniel Morgan, MD, MS ; Birgir Johannsson, MD ; Theodoros Kelesidis, MD ; Daniel Z. Uslan, MD, MS ; Heather Young, MD ; Joseph Cantey, MD ; Eli Perencevich, MD, MS, FIDSA, FSHEA ; Arjun Srinivasan, MD, FSHEA ; Edward Septimus, MD, FIDSA, FSHEA ; Ramanan Laxminarayan, PhD, MPH

    770
    The Frequency Of Antibiotic De-Escalation Over Six US Hospitals: Results from a Multicenter Cross-Sectional Study
    Daniel Morgan, MD, MS ; Birgir Johannsson, MD ; Marin Schweizer, PhD ; Nikolay Braykov, BSE ; Scott A. Weisenberg, MD, MSc, DTM&H ; Daniel Z. Uslan, MD, MS ; Theodoros Kelesidis, MD ; Heather Young, MD ; Joseph Cantey, MD ; Edward Septimus, MD, FIDSA, FSHEA ; Arjun Srinivasan, MD, FSHEA ; Eli Perencevich, MD, MS, FIDSA, FSHEA ; Ramanan Laxminarayan, PhD, MPH

    772
    Aggregate Measures of Antifungal Use in Hospitalized Patients: Defined Daily Doses vs. Antimicrobial Days
    Nicholas Beyda, PharmD ; Dhara Shah, PharmD ; Jessica Cottreau, PharmD ; Miguel Salazar, PharmD, PhD ; Craig Frost, RPh, MBA ; Kevin W. Garey, PharmD, M.S.

    CME Credits:


    Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 17th with the exception of research findings presented at the IDWeek press conferences.